This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1aio

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1aio.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1aio.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1aio| PDB=1aio | SCENE= }}
{{STRUCTURE_1aio| PDB=1aio | SCENE= }}
-
'''CRYSTAL STRUCTURE OF A DOUBLE-STRANDED DNA CONTAINING THE MAJOR ADDUCT OF THE ANTICANCER DRUG CISPLATIN'''
+
===CRYSTAL STRUCTURE OF A DOUBLE-STRANDED DNA CONTAINING THE MAJOR ADDUCT OF THE ANTICANCER DRUG CISPLATIN===
-
==Overview==
+
<!--
-
The success of cisplatin in cancer chemotherapy derives from its ability to crosslink DNA and alter the structure. Most cisplatin-DNA adducts are intrastrand d(GpG) and d(ApG) crosslinks, which unwind and bend the duplex to facilitate the binding of proteins that contain one or more high-mobility group (HMG) domains. When HMG-domain proteins such as HMG1, IXR (intrastrand-crosslink recognition) protein from yeast, or human upstream-binding factor (hUBF) bind cisplatin intrastrand crosslinks, they can be diverted from their natural binding sites on the genome and shield the adducts from excision repair. These activities sensitize cells to cisplatin and contribute to its cytotoxic properties. Crystallographic information about the structure of cisplatin-DNA adducts has been limited to short single-stranded deoxyoligonucleotides such as cis-[Pt(NH3)2(d(pGpG))]. Here we describe the X-ray structure at 2.6 A resolution of a double-stranded DNA dodecamer containing this adduct. Our information provides, to our knowledge, the first crystallographic look at a platinated DNA duplex and should help the design of new platinum and other metal crosslinking antitumour drug candidates. Moreover, the structure reveals a unique fusion of A- and B-type DNA segments that could be of more general importance.
+
The line below this paragraph, {{ABSTRACT_PUBMED_7566180}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 7566180 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_7566180}}
==About this Structure==
==About this Structure==
Line 28: Line 32:
[[Category: Modified]]
[[Category: Modified]]
[[Category: Right handed dna]]
[[Category: Right handed dna]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 10:19:07 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jun 30 16:55:56 2008''

Revision as of 13:55, 30 June 2008

Image:1aio.png

Template:STRUCTURE 1aio

CRYSTAL STRUCTURE OF A DOUBLE-STRANDED DNA CONTAINING THE MAJOR ADDUCT OF THE ANTICANCER DRUG CISPLATIN

Template:ABSTRACT PUBMED 7566180

About this Structure

This structure supersedes the now removed PDB entry 1gpg. Full crystallographic information is available from OCA.

Reference

Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin., Takahara PM, Rosenzweig AC, Frederick CA, Lippard SJ, Nature. 1995 Oct 19;377(6550):649-52. PMID:7566180

Page seeded by OCA on Mon Jun 30 16:55:56 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1aio"
Personal tools